Trial Profile
A comparative randomized study for the evaluation of the overlaying effect of Selegiline or Zonisamide over Levodopa in Parkinson's disease
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 21 Dec 2018
Price :
$35
*
At a glance
- Drugs Selegiline (Primary) ; Zonisamide (Primary) ; Levodopa
- Indications Parkinson's disease
- Focus Therapeutic Use
- 14 Dec 2018 Status changed from not yet recruiting to recruiting.
- 21 Jun 2016 New trial record